New evidence has linked physical activity with improved colon health, underscoring the vital role of exercise in cancer ...

Aitia, the leader in computationally discovering and applying new knowledge of biological causes of disease to pharmaceutical discovery and development, today announced a collaboration with Gustave ...

Jorge Mato Frontela, Miguel Cohen Suarez, Fletch Rydell and Trisha Santanam were chosen by a faculty committee chaired by Professor Erika Weinthal of the Nicholas School of the Environment. The award ...

The insurer paid out 9.24% more than in 2023, with a sharp increase in cancer claims, while cardiovascular claims showed an ...

Chronic kidney disease (CKD) and hypertension are common health problems among childhood cancer survivors with potentially life-threatening sequelae.

Alternative cancer clinics spent over an US$15 million on Google ad spaces, generating millions of website visits from people ...

Anticipated AMPLIFY-7P Phase 2 interim analysis expected in Q3 2025.

Under the partnership, GE HealthCare will serve as the technology partner, and TMC will be the clinical oncology partner.

Global Akeega sales will reach $676 million by 2030, while Talzenna and saruparib reach $618 million and $628 million ...

Rising brain tumor cases in India, with advanced imaging techniques and treatment options offering hope for better outcomes.

Akeega – which combines the active ingredients in J&J's PARP inhibitor Zejula (niraparib) and androgen blocker Zytiga ...